These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21808038)

  • 1. Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency.
    Xia C; Panda SP; Marohnic CC; Martásek P; Masters BS; Kim JJ
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13486-91. PubMed ID: 21808038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase.
    Marohnic CC; Panda SP; Martásek P; Masters BS
    J Biol Chem; 2006 Nov; 281(47):35975-82. PubMed ID: 16998238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.
    Marohnic CC; Huber Iii WJ; Patrick Connick J; Reed JR; McCammon K; Panda SP; Martásek P; Backes WL; Masters BS
    Arch Biochem Biophys; 2011 Sep; 513(1):42-50. PubMed ID: 21741353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
    Flück CE; Nicolo C; Pandey AV
    Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered human CYP3A4 activity caused by Antley-Bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro system.
    Moutinho D; Marohnic CC; Panda SP; Rueff J; Masters BS; Kranendonk M
    Drug Metab Dispos; 2012 Apr; 40(4):754-60. PubMed ID: 22252407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450.
    Hamdane D; Xia C; Im SC; Zhang H; Kim JJ; Waskell L
    J Biol Chem; 2009 Apr; 284(17):11374-84. PubMed ID: 19171935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding.
    Xia C; Hamdane D; Shen AL; Choi V; Kasper CB; Pearl NM; Zhang H; Im SC; Waskell L; Kim JJ
    J Biol Chem; 2011 May; 286(18):16246-60. PubMed ID: 21345800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of Anopheles minimus Mosquito NADPH-cytochrome P450 oxidoreductase (CYPOR) and mutagenesis analysis.
    Sarapusit S; Lertkiatmongkol P; Duangkaew P; Rongnoparut P
    Int J Mol Sci; 2013 Jan; 14(1):1788-801. PubMed ID: 23325047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase.
    Shen AL; O'Leary KA; Kasper CB
    J Biol Chem; 2002 Feb; 277(8):6536-41. PubMed ID: 11742006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric enzymes of cytochrome P450 oxidoreductase and neuronal nitric-oxide synthase reductase domain reveal structural and functional differences.
    Roman LJ; McLain J; Masters BS
    J Biol Chem; 2003 Jul; 278(28):25700-7. PubMed ID: 12730215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.
    Kranendonk M; Marohnic CC; Panda SP; Duarte MP; Oliveira JS; Masters BS; Rueff J
    Arch Biochem Biophys; 2008 Jul; 475(2):93-9. PubMed ID: 18455494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.
    Marohnic CC; Panda SP; McCammon K; Rueff J; Masters BS; Kranendonk M
    Drug Metab Dispos; 2010 Feb; 38(2):332-40. PubMed ID: 19884324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antley-Bixler syndrome or POR deficiency?].
    Tomková M; Marohnic CC; Baxová A; Martásek P
    Cas Lek Cesk; 2008; 147(5):261-5. PubMed ID: 18630181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Functional Studies of the Membrane-Binding Domain of NADPH-Cytochrome P450 Oxidoreductase.
    Xia C; Shen AL; Duangkaew P; Kotewong R; Rongnoparut P; Feix J; Kim JP
    Biochemistry; 2019 May; 58(19):2408-2418. PubMed ID: 31009206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and kinetic investigations of the carboxy terminus of NADPH-cytochrome P450 oxidoreductase.
    Hubbard PA; Xia C; Shen AL; Kim JP
    Arch Biochem Biophys; 2021 Apr; 701():108792. PubMed ID: 33556357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational evolution of the cofactor-binding site of cytochrome P450 reductase yields variants with increased activity towards specific cytochrome P450 enzymes.
    Strohmaier SJ; Huang W; Baek JM; Hunter DJB; Gillam EMJ
    FEBS J; 2019 Nov; 286(22):4473-4493. PubMed ID: 31276316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a NADPH-cytochrome P450 oxidoreductase (CYPOR) and heme oxygenase 1 fusion protein implies a conformational change in CYPOR upon NADPH/NADP
    Sugishima M; Sato H; Wada K; Yamamoto K
    FEBS Lett; 2019 Apr; 593(8):868-875. PubMed ID: 30883732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
    Jin Y; Chen M; Penning TM; Miller WL
    Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide synthase. Comparisons with NADPH-cytochrome P450 oxidoreductase.
    Zhang J; Martàsek P; Paschke R; Shea T; Siler Masters BS; Kim JJ
    J Biol Chem; 2001 Oct; 276(40):37506-13. PubMed ID: 11473123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the transmembrane structure and dynamics of microsomal NADPH-cytochrome P450 oxidoreductase by solid-state NMR.
    Huang R; Yamamoto K; Zhang M; Popovych N; Hung I; Im SC; Gan Z; Waskell L; Ramamoorthy A
    Biophys J; 2014 May; 106(10):2126-33. PubMed ID: 24853741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.